-
Mashup Score: 1
In one of the opening workshops at ASGCT 2024, topics around delivery methods for gene therapies and approaches to expand the gene editing toolbox dominated the discussion. The quality of the presentations bodes well for a busy week in Baltimore.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0
Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate fordadistrogene movaparvovec after acknowledging the sudden death of a young boy who received the treatment last year.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 2Online Event - 4 hour(s) ago
Developing a biosimilar drug requires screening many samples originating from different cell lines to select the most appropriate ones for further process development. Each sample needs to be characterized by their critical q uality attributes, such as glycosylation or charge variants, which can be used to identify potentially harmful modifications in the samples. Common techniques used to determine the charge variants of a sample, such as ion exchange chromatography, are time- and material-consuming and
Source: www.workcast.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 3
Internal neural compass which the human brain uses to orientate itself in space and navigate through the environment has been identified.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1
Solvias says its new center complements its biologics and CGT sites in Europe and expands its testing capabilities in the United States.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0
The Crick Institute plans to leverage Broken String’s DNA break-mapping platform to develop novel applications for ALS treatments.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 2Viral Advantage: Prologue Medicines is Here to Release the Viral Proteome's Therapeutic Potential - 5 hour(s) ago
Prologue Medicines’ platform combines computation and high-throughput biology to decode millennia of viral evolution.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 5
A U.S. District Court judge has granted Vizgen’s motion to expand its antitrust case against rival 10x Genomics and Harvard University.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 1
In one of the opening workshops at ASGCT 2024, topics around delivery methods for gene therapies and approaches to expand the gene editing toolbox dominated the discussion. The quality of the presentations bodes well for a busy week in Baltimore.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
-
Mashup Score: 0
Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate fordadistrogene movaparvovec after acknowledging the sudden death of a young boy who received the treatment last year.
Source: www.genengnews.comCategories: General Medicine News, Future of MedicineTweet
. @ASGCTherapy 2024: #GeneTherapy Delivery and Development Dominates Opening Workshop. Learn More: https://t.co/6gaLWpEyJB https://t.co/1u9ZmMeivC